Skip to main content
. 2022 Feb 12;22:76. doi: 10.1186/s12935-022-02499-w

Fig. 1.

Fig. 1

Low expression of ZHX2 was associated with poor prognosis in thyroid cancer. A ZHX2 expression was measured in human tissue samples using western blotting (WB). GAPDH was used as the internal control. Thyroid tumour tissues (T); adjacent non-tumour tissues (P). B ZHX2 mRNA levels were evaluated by RT–qPCR in human specimens. **p < 0.01, the p value was determined by Student’s t test. C Representative images of ZHX2 immunostaining in thyroid adjacent non-tumour and thyroid tumour tissues (Image magnifications of 100 × , bar: 100 μm). D Statistical analysis of ZHX2 expression in thyroid adjacent non-tumour and thyroid tumour tissues. Significant differences were determined by the chi-squared test. E Kaplan–Meier survival curves of thyroid cancer patients with ZHX2 expression were analysed by online software